Abstract
Background: Cancer patients are at increased risks of novelcoronavirus disease 2019 (COVID-19). Currently, surgical strategies for cancer patients with COVID-19 are generally suggested to be properly delayed. Case presentation:We presented a 69-year-old Chinese female colon cancer patientwith COVID-19, the first case accepted the surgical treatment during the epidemic season in China. Thepatient developed a fever on January 28, 2020. After treatments with Ceftriaxone and Abidol, her fever was not reduced yet. A repeat chest computed tomography (CT) scan showed the infectious lesions significantly exacerbated, with a positive result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid. An abdomen CT scan indicated the tumor of ascending colon with local wrapped changes. She was diagnosed with ‘Severe novel coronavirus pneumonia’ and ‘Incomplete bowel obstruction: Colon cancer?’. After actively anti-inflammatory and anti-viral therapies, aright colectomy with lymph node dissection was performed on March 11. The pathological changes of tissue specimens were further investigated.The patient successfully recovered from COVID-19 and surgery, without any postoperative related complications, and was discharged on the 9th day after operation. No case of surgeon, nurse or anesthetist in our team infected by SARS-CoV-2 occurred. Microscopically, significant degeneration, necrosis and slough of focal intestinal and colonic mucosal epithelial cells were observed. Conclusions:It is meaningful and imperative to share our experience to protect health care personnel from SARS-CoV-2infection and to provide references for optimizing treatment of cancer patient, at least for the operative intervention absolutely necessary or emergency surgery,during the outbreak of COVID-19.